title: Ca-asp bound X-ray structure and inhibition of Bacillus anthracis dihydroorotase (DHOase).
abstract: Dihydroorotase (DHOase) is the third enzyme in the de novo pyrimidine synthesis pathway and is responsible for the reversible cyclization of carbamyl-aspartate (Ca-asp) to dihydroorotate (DHO). DHOase is further divided into two classes based on several structural characteristics, one of which is the length of the flexible catalytic loop that interacts with the substrate, Ca-asp, regulating the enzyme activity. Here, we present the crystal structure of Class I Bacillus anthracis DHOase with Ca-asp in the active site, which shows the peptide backbone of glycine in the shorter loop forming the necessary hydrogen bonds with the substrate, in place of the two threonines found in Class II DHOases. Despite the differences in the catalytic loop, the structure confirms that the key interactions between the substrate and active site residues are similar between Class I and Class II DHOase enzymes, which we further validated by mutagenesis studies. B. anthracis DHOase is also a potential antibacterial drug target. In order to identify prospective inhibitors, we performed high-throughput screening against several libraries using a colorimetric enzymatic assay and an orthogonal fluorescence thermal binding assay. Surface plasmon resonance was used for determining binding affinity (KD) and competition analysis with Ca-asp. Our results highlight that the primary difference between Class I and Class II DHOase is the catalytic loop. We also identify several compounds that can potentially be further optimized as potential B. anthracis inhibitors.
authors: Center for Biomolecular Sciences and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 900 S, Ashland, IL 60607, USA.
authors: Amy J
authors: AJ
authors: Rice
authors: Center for Biomolecular Sciences and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 900 S, Ashland, IL 60607, USA.
authors: Hao
authors: H
authors: Lei
authors: Center for Biomolecular Sciences and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 900 S, Ashland, IL 60607, USA.
authors: Bernard D
authors: BD
authors: Santarsiero
authors: Center for Biomolecular Sciences and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 900 S, Ashland, IL 60607, USA. Electronic address: danielhl@uic.edu.
authors: Hyun
authors: H
authors: Lee
authors: Center for Biomolecular Sciences and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 900 S, Ashland, IL 60607, USA. Electronic address: mjohnson@uic.edu.
authors: Michael E
authors: ME
authors: Johnson
mesh_terms: D000881:Anthrax / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology; D001408:Bacillus anthracis / Q000737:chemistry / Q000201:enzymology* / Q000378:metabolism; D018360:Crystallography, X-Ray; D004080:Dihydroorotase / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular; D011487:Protein Conformation
chemical_list: D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D004080:Dihydroorotase
keywords: Bacillus anthracis; Dihydroorotase (DHOase); High-throughput screening (HTS); Surface plasmon resonance (SPR)